切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Inward Rectifier Potassium (Kir) Channels - constitutive androstane receptor (CAR) - interleukin receptor - CaM-KK

10 件产品

每页
清除全部
  1. STO-609 acetate
    B6787 STO-609 acetate
    Target: CaM-KK
    Summary: Ca2+-钙调蛋白依赖性蛋白激酶激酶抑制剂
      Soluble in DMSO
  2. CITCO
    B7468 CITCO
     1 Citation
    Target: constitutive androstane receptor (CAR)
    Summary: 组成型雄激素受体(CAR)激动剂
      Soluble in DMSO
  3. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  4. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  5. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  6. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  7. Dexamethasone acetate
    B1926 Dexamethasone acetate
    中文名: 醋酸地塞米松
    Target: Glucocorticoid Receptors|interleukin receptor
    Summary: IL受体调节剂
      ≥13.35 mg/mL
      insoluble in H2O
  8. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  9. Dexamethasone (DHAP)
    A2324 Dexamethasone (DHAP)
    中文名: 地塞米松
    Target: interleukin receptor
    Summary: 糖皮质激素,抗炎活性
      ≥19.623 mg/mL
      insoluble in H2O
  10. Glimepiride
    A4033 Glimepiride
    中文名: 格列美脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 磺酰脲类化合物
      ≥21.45 mg/mL
      insoluble in H2O

10 件产品

每页